(Q37779817)

23 August 2017

1 reference

title

Vaccines based on whole recombinant Saccharomyces cerevisiae cells (English)

1 reference

23 August 2017

main subject

Saccharomyces cerevisiae

1 reference

Andressa Ardiani

1

1 reference

23 August 2017

Jack P Higgins

series ordinal

2

1 reference

23 August 2017

James W Hodge

series ordinal

3

1 reference

23 August 2017

publication date

1 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

1060-1069

1 reference

Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges

23 August 2017

cites work

1 reference

12 December 2020

The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing

1 reference

12 December 2020

Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells

1 reference

12 December 2020

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors

1 reference

12 December 2020

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

1 reference

12 December 2020

Resistance of murine lung tumors to xenobiotic-induced cytotoxicity

1 reference

12 December 2020

Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations

1 reference

12 December 2020

Saccharomyces cerevisiae: a versatile eukaryotic system in virology.

1 reference

12 December 2020

Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy

1 reference

12 December 2020

Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses

1 reference

12 December 2020

Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms

1 reference

12 December 2020

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

1 reference

12 December 2020

Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

1 reference

12 December 2020

Yeasts encoding tumour antigens in cancer immunotherapy

1 reference

12 December 2020

Immunological aspects of cancer chemotherapy

1 reference

12 December 2020

Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.

1 reference

12 December 2020

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

1 reference

12 December 2020

Cancer vaccines: moving beyond current paradigms

1 reference

12 December 2020

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

1 reference

12 December 2020

Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy

1 reference

12 December 2020

Combining radiation and immunotherapy for synergistic antitumor therapy.

1 reference

12 December 2020

Human hepatitis B vaccine from recombinant yeast

1 reference

12 December 2020

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

12 December 2020

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

1 reference

12 December 2020

Generation of a prophylactic melanoma vaccine using whole recombinant yeast expressing MART-1.

1 reference

12 December 2020

Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects

1 reference

12 December 2020

Immunotherapy and chemotherapy--a practical partnership

1 reference

12 December 2020

An antimicrobial activity of cytolytic T cells mediated by granulysin

1 reference

12 December 2020

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

1 reference

12 December 2020

Immunobiology of HPV and HPV vaccines

1 reference

12 December 2020

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?

1 reference

12 December 2020

Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen

1 reference

12 December 2020

Hepatitis C virus infection and immunomodulatory therapies

1 reference

12 December 2020

1 reference

12 December 2020

Enhancing immune responses to tumor-associated antigens

1 reference

12 December 2020

Human dendritic cell interactions with whole recombinant yeast: implications for HIV-1 vaccine development.

1 reference

12 December 2020

Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans

1 reference

12 December 2020

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

12 December 2020

ras oncogenes in human cancer: a review

1 reference

12 December 2020

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

1 reference

12 December 2020

Combining Vaccines with Conventional Therapies for Cancer

1 reference

12 December 2020

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

1 reference

12 December 2020

Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence

1 reference

12 December 2020

10.1111/J.1567-1364.2010.00665.X

Identifiers

DOI

1 reference

23 August 2017

0 references

1 reference